These contradictory trends are reinforced by changes we see in the market access stakeholders’ map: • Payers have an increased influence on physicians’ prescriptions. They scrutinize drugs ...

“It is time to develop a joint strategy as a community, development stakeholders, quality regulators and TPHPA. After formulating this strategy we will present it to the public for review and ...

Here is the list of available roadmaps with more being actively worked upon. Have a look at the get started page that might help you pick up a path.